Menu
Back to User profile » Prof. Dr. Ali S Abdelhameed
Papers published by Prof. Dr. Ali S Abdelhameed:
LC–MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation
Attwa MW, Abdelhameed AS, Kadi AA
Drug Design, Development and Therapy 2021, 15:3915-3925
Published Date: 15 September 2021
Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach
Abdelhameed AS, Attwa MW, Kadi AA
Drug Design, Development and Therapy 2020, 14:5259-5273
Published Date: 30 November 2020
LC-MS/MS Estimation of the Anti-Cancer Agent Tandutinib Levels in Human Liver Microsomes: Metabolic Stability Evaluation Assay
Attwa MW, Abdelhameed AS, Al-Shakliah NS, Kadi AA
Drug Design, Development and Therapy 2020, 14:4439-4449
Published Date: 23 October 2020
Metabolic Stability Assessment of New PARP Inhibitor Talazoparib Using Validated LC–MS/MS Methodology: In silico Metabolic Vulnerability and Toxicity Studies
Attwa MW, Kadi AA, Abdelhameed AS, Alhazmi HA
Drug Design, Development and Therapy 2020, 14:783-793
Published Date: 25 February 2020
Antiproliferative activity and possible mechanism of action of certain 5-methoxyindole tethered C-5 functionalized isatins
Almutairi MS, Hassan ES, Keeton AB, Piazza GA, Abdelhameed AS, Attia MI
Drug Design, Development and Therapy 2019, 13:3069-3078
Published Date: 27 August 2019
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling
Abdel-Aziz HA, Eldehna WM, Keeton AB, Piazza GA, Kadi AA, Attwa MW, Abdelhameed AS, Attia MI
Drug Design, Development and Therapy 2017, 11:2333-2346
Published Date: 9 August 2017